Logo image of EB

EVENTBRITE INC-CLASS A (EB) Stock Fundamental Analysis

NYSE:EB - New York Stock Exchange, Inc. - US29975E1091 - Common Stock - Currency: USD

2.1  -0.01 (-0.47%)

After market: 2.1 0 (0%)

Fundamental Rating

3

Taking everything into account, EB scores 3 out of 10 in our fundamental rating. EB was compared to 72 industry peers in the Entertainment industry. The financial health of EB is average, but there are quite some concerns on its profitability. EB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EB had negative earnings in the past year.
EB had a positive operating cash flow in the past year.
In the past 5 years EB always reported negative net income.
EB had a positive operating cash flow in 4 of the past 5 years.
EB Yearly Net Income VS EBIT VS OCF VS FCFEB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

EB has a Return On Assets (-2.07%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -9.15%, EB is in line with its industry, outperforming 56.94% of the companies in the same industry.
Industry RankSector Rank
ROA -2.07%
ROE -9.15%
ROIC N/A
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
EB Yearly ROA, ROE, ROICEB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

EB's Gross Margin of 69.73% is amongst the best of the industry. EB outperforms 81.94% of its industry peers.
In the last couple of years the Gross Margin of EB has grown nicely.
EB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
EB Yearly Profit, Operating, Gross MarginsEB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

EB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EB has been reduced compared to 1 year ago.
Compared to 5 years ago, EB has more shares outstanding
The debt/assets ratio for EB has been reduced compared to a year ago.
EB Yearly Shares OutstandingEB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EB Yearly Total Debt VS Total AssetsEB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.75, we must say that EB is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.75, EB is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
EB has a debt to FCF ratio of 8.82. This is a slightly negative value and a sign of low solvency as EB would need 8.82 years to pay back of all of its debts.
EB's Debt to FCF ratio of 8.82 is fine compared to the rest of the industry. EB outperforms 65.28% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that EB has dependencies on debt financing.
The Debt to Equity ratio of EB (1.24) is worse than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 8.82
Altman-Z -0.75
ROIC/WACCN/A
WACC5.94%
EB Yearly LT Debt VS Equity VS FCFEB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

EB has a Current Ratio of 1.51. This is a normal value and indicates that EB is financially healthy and should not expect problems in meeting its short term obligations.
EB has a better Current ratio (1.51) than 70.83% of its industry peers.
A Quick Ratio of 1.51 indicates that EB should not have too much problems paying its short term obligations.
EB has a Quick ratio of 1.51. This is in the better half of the industry: EB outperforms 70.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
EB Yearly Current Assets VS Current LiabilitesEB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

EB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.04%, which is quite impressive.
Looking at the last year, EB shows a decrease in Revenue. The Revenue has decreased by -0.32% in the last year.
Measured over the past years, EB shows a decrease in Revenue. The Revenue has been decreasing by -0.11% on average per year.
EPS 1Y (TTM)37.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-800%
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-12.87%

3.2 Future

EB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.68% yearly.
The Revenue is expected to grow by 4.68% on average over the next years.
EPS Next Y-82.98%
EPS Next 2Y-14.8%
EPS Next 3Y-2.93%
EPS Next 5Y27.68%
Revenue Next Year-7.72%
Revenue Next 2Y1.6%
Revenue Next 3Y5.4%
Revenue Next 5Y4.68%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EB Yearly Revenue VS EstimatesEB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
EB Yearly EPS VS EstimatesEB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EB Price Earnings VS Forward Price EarningsEB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EB is valued cheaply inside the industry as 90.28% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.28
EV/EBITDA N/A
EB Per share dataEB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as EB's earnings are expected to decrease with -2.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.8%
EPS Next 3Y-2.93%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVENTBRITE INC-CLASS A

NYSE:EB (4/25/2025, 8:04:00 PM)

After market: 2.1 0 (0%)

2.1

-0.01 (-0.47%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-01 2025-05-01
Inst Owners75.97%
Inst Owner Change-0.21%
Ins Owners5.02%
Ins Owner Change39.7%
Market Cap198.72M
Analysts76.92
Price Target4.73 (125.24%)
Short Float %5.3%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.44%
Min EPS beat(2)-64.87%
Max EPS beat(2)69.74%
EPS beat(4)2
Avg EPS beat(4)22.29%
Min EPS beat(4)-64.87%
Max EPS beat(4)118.39%
EPS beat(8)6
Avg EPS beat(8)33.92%
EPS beat(12)8
Avg EPS beat(12)28.12%
EPS beat(16)10
Avg EPS beat(16)21.28%
Revenue beat(2)0
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-2.55%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-2.47%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)-0.39%
Revenue beat(8)1
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-1.07%
Revenue beat(16)5
Avg Revenue beat(16)0.62%
PT rev (1m)3.54%
PT rev (3m)-8.48%
EPS NQ rev (1m)-13%
EPS NQ rev (3m)-100.89%
EPS NY rev (1m)-8488.89%
EPS NY rev (3m)-8488.89%
Revenue NQ rev (1m)0.4%
Revenue NQ rev (3m)-3.2%
Revenue NY rev (1m)-4.86%
Revenue NY rev (3m)-11.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF 7.28
P/OCF 5.59
P/B 1.17
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)0.29
FCFY13.74%
OCF(TTM)0.38
OCFY17.9%
SpS3.44
BVpS1.8
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.07%
ROE -9.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.73%
FCFM 8.4%
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
F-Score7
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 8.82
Debt/EBITDA N/A
Cap/Depr 54.79%
Cap/Sales 2.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z -0.75
F-Score7
WACC5.94%
ROIC/WACCN/A
Cap/Depr(3y)45.61%
Cap/Depr(5y)35.63%
Cap/Sales(3y)2.15%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-800%
EPS Next Y-82.98%
EPS Next 2Y-14.8%
EPS Next 3Y-2.93%
EPS Next 5Y27.68%
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-12.87%
Revenue Next Year-7.72%
Revenue Next 2Y1.6%
Revenue Next 3Y5.4%
Revenue Next 5Y4.68%
EBIT growth 1Y23.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year162.04%
EBIT Next 3Y47.61%
EBIT Next 5Y30.1%
FCF growth 1Y130.4%
FCF growth 3Y-29.09%
FCF growth 5Y12.63%
OCF growth 1Y87.05%
OCF growth 3Y-23.38%
OCF growth 5Y4.42%